Tricuspid insufficiency
Methodology & AI Transparency ⓘ
Tricuspid insufficiency Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: For patients presenting with Tricuspid insufficiency (ICD-10-CM I07.1), Heart & Cardiovascular Disease protocols prioritize cardiopulmonary biomarker stratification [Tricuspid insufficiency I07.1] paired with baseline and interval NT-proBNP [Tricuspid insufficiency I07.1] assessment.
- 2 Real-world patient consensus: Federal ICD-10-CM code I07.1 categorizes Tricuspid insufficiency under Heart & Cardiovascular Disease.
- 3 Typical cash cost range: Clinicians assessing Tricuspid insufficiency focus on subendocardial perfusion deficits [Tricuspid insufficiency I07.1] and targeted history.
- 4 Top reported side effects / signs: Longitudinal Tricuspid insufficiency monitoring tracks NT-proBNP [Tricuspid insufficiency I07.1] toward < 100 pg/mL (I07.1).
Ask our AI Specialists anything about Tricuspid insufficiency
What Is Tricuspid insufficiency?
For patients presenting with Tricuspid insufficiency (ICD-10-CM I07.1), Heart & Cardiovascular Disease protocols prioritize cardiopulmonary biomarker stratification [Tricuspid insufficiency I07.1] paired with baseline and interval NT-proBNP [Tricuspid insufficiency I07.1] assessment.
Pathophysiology, Underlying Causes & Clinical Presentation
In Tricuspid insufficiency (I07.1), physiological disruption stems from subendocardial perfusion deficits [Tricuspid insufficiency I07.1], informing Heart & Cardiovascular Disease protocols that track High-Sensitivity Troponin I [Tricuspid insufficiency I07.1] (< 14 ng/L (I07.1)).
Common Symptoms & Clinical Signs
- • Presentation of Tricuspid insufficiency (I07.1): unexplained lower-extremity ankle in Tricuspid insufficiency (I07.1: edema or rapid)
- • Secondary Tricuspid insufficiency clinical sign: reduced exercise tolerance in Tricuspid insufficiency (I07.1: and premature cardiovascular)
- • Symptom flares in Tricuspid insufficiency correlating with NT-proBNP [Tricuspid insufficiency I07.1] deviation outside < 100 pg/mL (I07.1)
- • Functional heart & vascular impact requiring cardiopulmonary biomarker stratification [Tricuspid insufficiency I07.1] evaluation (I07.1)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Tricuspid insufficiency Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | I07.1 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Heart & Cardiovascular Disease | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: NT-proBNP [Tricuspid insufficiency I07.1] | < 100 pg/mL (I07.1) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: High-Sensitivity Troponin I [Tricuspid insufficiency I07.1] | < 14 ng/L (I07.1) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Apolipoprotein B (ApoB) [Tricuspid insufficiency I07.1] | < 70 mg/dL (I07.1) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Tricuspid insufficiency
Treatment selection for Tricuspid insufficiency depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Tricuspid insufficiency)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Pharmacological Inhibition of CETP (Cholesteryl Ester Transfer Protein) Increases CETP inhibitors evacetrapib and torcetrapib increase apoA1 in HDL subspecies that contain apoC3 and other HDL subspecies associated with higher risk of coronary heart disease. Arteriosclerosis, thrombosis, and vascular biology • 2022-02-15 • Phase III Randomized Trial | N = 126 | 88/100 | PMID 34937388 ↗ |
Tricuspid insufficiency Patient Community & “People Like Me” Threads
Filter Tricuspid insufficiency community threads and patient logs by age, biological sex, dosage, and treatment duration.